Ludwig, S. http://orcid.org/0000-0002-5752-4951
Kalbacher, D.
Schofer, N.
Schäfer, A.
Koell, B.
Seiffert, M.
Schirmer, J.
Schäfer, U.
Westermann, D.
Reichenspurner, H.
Blankenberg, S.
Lubos, E.
Conradi, L.
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 10 August 2020
Accepted: 2 October 2020
First Online: 19 October 2020
Compliance with ethical standards
:
: SL received non-financial support from Edwards Lifesciences, outside the submitted work. MS reports non-financial support from Abbott Vascular, Biotronik, Boehringer Ingelheim, Boston Scientific, Edwards Lifesciences, Nicolai Medizintechnik, OrbusNeich Medical, personal fees from Abiomed, Amgen, AstraZeneca, Bayer Healthcare, Bristol-Myers Squibb, Boston Scientific, Medtronic and Philips and grants from Philips, outside the submitted work. US is a consultant for Abbott Vascular, received speaker honoraria and travel compensation from Abbott Vascular and received study grants from Abbott Vascular and Neovasc. DW reports personal fees from AstraZeneca, Bayer, Berlin-Chemie and Novartis, outside the submitted work. EL reports grants and personal fees from Abbott and personal fees from Edwards Lifesciences, during the conduct of the study. Outside the submitted work EL received personal fees from Abiomed, Astra Zeneca, Bayer, New Valve Technology and Novartis. LC received lecture fees from Abbott and Neovasc and is a proctor as well as advisory board member for Abbott and Neovasc during the conduct of the study. All other authors report no conflicts of interest.